Group 1 - The company Zhejiang Zhenyuan (000705.SZ) announced that its biological directional synthesis project S1 production line is scheduled to commence operations on August 30, 2025, and is gradually releasing capacity in response to market demand [1]. - There are concerns from investors regarding potential significant losses in the fourth quarter and whether the company's transformation towards synthetic biology is facing major issues [3].